08:30-09:00 | Highlights from the 2024 ATA guidelines on the management of thyroid nodules Susan Mandel (University of Pennsylvania, USA) | |
09:00-09:30 | Changing perspectives in the KTA guideline for thyroid cancer Eun Kyung Lee (National Cancer Center, Korea) | |
09:30-10:00 | Recent update in guidelines for subclinical hypothyroidism Eu Jeong Ku (Seoul National University, Korea) |
08:30-09:00 | Thyroid hormone and NAFLD Rohit A. Sinha (Sanjay Gandhi Post Graduate Institute of Medical Sciences, India) | |
09:00-09:30 | IL-17A-producing γδ T cells govern metabolic complications of thyrotoxicosis Hyon-Seung Yi (Chungnam National University, Korea) | |
09:30-10:00 | Thyroid hormones in diabetes and aging Yong-Ho Lee (Yonsei University, Korea) |
11:20-11:50 | Long term anti-thyroid drug therapy Ken Okamura (Kyushu university, Japan) | |
11:50-12:20 | Revolutionizing management of Graves' disease: integrating new technologies for optimal patient care Jae Hoon Moon (Seoul National University, Korea) | |
12:20-12:50 | Current and emerging therapies for thyroid eye disease Jin Sook Yoon (Yonsei University, Korea) |